Juxtaglomerular cell hyperplasia and secondary hyperaldosteronism (Bartter's syndrome): a re-evaluation of the pathophysiology.
D000136:Acid-Base Equilibrium; D000293:Adolescent; D000328:Adult; D000450:Aldosterone / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D006929:Hyperaldosteronism / Q000150:complications*; D006965:Hyperplasia; D007223:Infant; D007606:Juxtaglomerular Apparatus / Q000473:pathology*; D007668:Kidney / Q000502:physiology; D007674:Kidney Diseases / Q000473:pathology; D007677:Kidney Function Tests; D008297:Male; D009393:Nephritis / Q000473:pathology; D011188:Potassium / Q000378:metabolism; D011189:Potassium Chloride / Q000494:pharmacology; D012083:Renin / Q000097:blood / Q000378:metabolism; D012965:Sodium Chloride / Q000494:pharmacology; D013148:Spironolactone / Q000494:pharmacology; D014882:Water-Electrolyte Balance
D013148:Spironolactone; D012965:Sodium Chloride; D000450:Aldosterone; D011189:Potassium Chloride; D012083:Renin; D011188:Potassium